VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX)
CUSIP: 92532F100
Q4 2020 13F Holders as of 31 Dec 2020
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 254,406,089
- Total 13F shares
- 238,859,796
- Share change
- -3,154,898
- Total reported value
- $56,374,238,590
- Put/Call ratio
- 132%
- Price per share
- $236.34
- Number of holders
- 952
- Value change
- -$907,518,096
- Number of buys
- 486
- Number of sells
- 436
Quarterly Holders Quick Answers
What is CUSIP 92532F100?
CUSIP 92532F100 identifies VRTX - VERTEX PHARMACEUTICALS INC / MA - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 92532F100:
Top shareholders of VRTX - VERTEX PHARMACEUTICALS INC / MA - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock Finance, Inc. |
13F
|
Company |
9.9%
|
25,175,541
|
$6,850,768,000 | — | 30 Sep 2020 | |
| VANGUARD GROUP INC |
13F
|
Company |
8.1%
|
20,689,919
|
$5,630,141,000 | — | 30 Sep 2020 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
8%
|
20,370,924
|
$5,543,336,000 | — | 30 Sep 2020 | |
| FMR LLC |
13F
|
Company |
7.9%
|
20,138,996
|
$5,480,224,000 | — | 30 Sep 2020 | |
| STATE STREET CORP |
13F
|
Company |
4.5%
|
11,361,946
|
$3,091,813,000 | — | 30 Sep 2020 | |
| Capital World Investors |
13F
|
Company |
4.5%
|
11,360,515
|
$3,091,419,000 | — | 30 Sep 2020 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
2.6%
|
6,599,551
|
$1,795,870,000 | — | 30 Sep 2020 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
2.4%
|
6,186,464
|
$1,683,460,000 | — | 30 Sep 2020 | |
| Capital International Investors |
13F
|
Company |
2.2%
|
5,486,084
|
$1,492,833,000 | — | 30 Sep 2020 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
2%
|
5,206,932
|
$1,416,910,000 | — | 30 Sep 2020 | |
| Clearbridge Investments, LLC |
13F
|
Company |
1.8%
|
4,471,280
|
$1,216,725,000 | — | 30 Sep 2020 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.5%
|
3,874,152
|
$1,052,026,000 | — | 30 Sep 2020 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
1.4%
|
3,609,084
|
$982,104,000 | — | 30 Sep 2020 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
1.4%
|
3,501,955
|
$952,952,000 | — | 30 Sep 2020 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1.2%
|
3,097,905
|
$843,002,000 | — | 30 Sep 2020 | |
| NORGES BANK |
13F
|
Company |
1.1%
|
2,862,254
|
$778,877,000 | — | 30 Sep 2020 | |
| Bank of New York Mellon Corp |
13F
|
Company |
1%
|
2,597,183
|
$706,745,000 | — | 30 Sep 2020 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.88%
|
2,239,810
|
$605,443,000 | — | 30 Sep 2020 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.85%
|
2,161,244
|
$588,118,000 | — | 30 Sep 2020 | |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main |
13F
|
Company |
0.81%
|
2,070,434
|
$563,406,515 | — | 30 Sep 2020 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.8%
|
2,043,727
|
$556,140,000 | — | 30 Sep 2020 | |
| HARDING LOEVNER LP |
13F
|
Company |
0.79%
|
2,000,541
|
$544,387,000 | — | 30 Sep 2020 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
0.75%
|
1,900,957
|
$517,279,000 | — | 30 Sep 2020 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
0.75%
|
1,900,157
|
$517,071,000 | — | 30 Sep 2020 | |
| WADDELL & REED FINANCIAL INC |
13F
|
Company |
0.68%
|
1,740,257
|
$473,559,000 | — | 30 Sep 2020 | |
| Legal & General Group Plc |
13F
|
Company |
0.66%
|
1,685,904
|
$458,767,000 | — | 30 Sep 2020 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.63%
|
1,614,043
|
$439,213,382 | — | 30 Sep 2020 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.58%
|
1,475,350
|
$401,473,000 | — | 30 Sep 2020 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.58%
|
1,473,110
|
$400,862,000 | — | 30 Sep 2020 | |
| Swiss National Bank |
13F
|
Company |
0.55%
|
1,390,175
|
$378,294,000 | — | 30 Sep 2020 | |
| GQG Partners LLC |
13F
|
Company |
0.55%
|
1,387,263
|
$377,399,000 | — | 30 Sep 2020 | |
| Sumitomo Mitsui Trust Group, Inc. |
13F
|
Company |
0.52%
|
1,317,959
|
$358,643,000 | — | 30 Sep 2020 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.51%
|
1,294,638
|
$352,297,000 | — | 30 Sep 2020 | |
| Capital Research Global Investors |
13F
|
Company |
0.49%
|
1,250,658
|
$340,329,000 | — | 30 Sep 2020 | |
| PUTNAM INVESTMENTS LLC |
13F
|
Company |
0.48%
|
1,219,186
|
$331,765,000 | — | 30 Sep 2020 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.47%
|
1,193,860
|
$324,874,000 | — | 30 Sep 2020 | |
| Invesco Ltd. |
13F
|
Company |
0.44%
|
1,130,967
|
$307,760,000 | — | 30 Sep 2020 | |
| FRED ALGER MANAGEMENT, LLC |
13F
|
Company |
0.42%
|
1,060,097
|
$288,474,000 | — | 30 Sep 2020 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.4%
|
1,028,168
|
$279,785,000 | — | 30 Sep 2020 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.4%
|
1,019,775
|
$277,501,000 | — | 30 Sep 2020 | |
| PICTET ASSET MANAGEMENT LTD |
13F
|
Company |
0.39%
|
980,847
|
$266,908,000 | — | 30 Sep 2020 | |
| Bellevue Group AG |
13F
|
Company |
0.38%
|
960,600
|
$261,398,000 | — | 30 Sep 2020 | |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC |
13F
|
Company |
0.36%
|
922,116
|
$250,926,000 | — | 30 Sep 2020 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.36%
|
912,012
|
$248,177,000 | — | 30 Sep 2020 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.33%
|
839,868
|
$228,416,000 | — | 30 Sep 2020 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
0.33%
|
829,763
|
$225,795,000 | — | 30 Sep 2020 | |
| EATON VANCE MANAGEMENT |
13F
|
Company |
0.32%
|
824,262
|
$224,298,000 | — | 30 Sep 2020 | |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.32%
|
813,622
|
$221,403,000 | — | 30 Sep 2020 | |
| Allianz Asset Management GmbH |
13F
|
Company |
0.31%
|
791,724
|
$215,444,000 | — | 30 Sep 2020 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.31%
|
777,637
|
$211,611,000 | — | 30 Sep 2020 |
Institutional Holders of VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX) as of Q4 2020
As of 31 Dec 2020,
VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX) was held by
952 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
238,859,796 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, FMR LLC, STATE STREET CORP, Capital World Investors, WELLINGTON MANAGEMENT GROUP LLP, ALLIANCEBERNSTEIN L.P., Capital International Investors, and Clearbridge Investments, LLC.
This page lists
954
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2020 vs Q3 2020 Across Filers
Q3 2020 holders
931
Q4 2020 holders
952
Holder diff
21
| Investor | Q3 2020 Shares | Q4 2020 Shares | Share Diff | Share Chg % | Q3 2020 Value $ | Q4 2020 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.